These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 21548718
1. Preparation of stable micron-sized crystalline irbesartan particles for the enhancement of dissolution rate. Zhang ZL, Le Y, Wang JX, Chen JF. Drug Dev Ind Pharm; 2011 Nov; 37(11):1357-64. PubMed ID: 21548718 [Abstract] [Full Text] [Related]
3. Improved dissolution of a poorly water soluble drug in solid dispersions with polymeric and non-polymeric hydrophilic additives. Chawla G, Bansal AK. Acta Pharm; 2008 Sep; 58(3):257-74. PubMed ID: 19103563 [Abstract] [Full Text] [Related]
4. Comparing various techniques to produce micro/nanoparticles for enhancing the dissolution of celecoxib containing PVP. Homayouni A, Sadeghi F, Varshosaz J, Garekani HA, Nokhodchi A. Eur J Pharm Biopharm; 2014 Sep; 88(1):261-74. PubMed ID: 24952357 [Abstract] [Full Text] [Related]
5. Production of Irbesartan Nanocrystals by High Shear Homogenisation and Ultra-Probe Sonication for Improved Dissolution Rate. Sridhar K, Rahman H, Sosnik A, Mukherjee U, Natarajan T, Siram K, Krishnamoorthy B. Curr Drug Deliv; 2016 Sep; 13(5):688-97. PubMed ID: 26563944 [Abstract] [Full Text] [Related]
6. Uniform nano-sized valsartan for dissolution and bioavailability enhancement: influence of particle size and crystalline state. Ma Q, Sun H, Che E, Zheng X, Jiang T, Sun C, Wang S. Int J Pharm; 2013 Jan 30; 441(1-2):75-81. PubMed ID: 23266761 [Abstract] [Full Text] [Related]
7. Effect of high pressure homogenization on physicochemical properties of curcumin nanoparticles prepared by antisolvent crystallization using HPMC or PVP. Homayouni A, Sohrabi M, Amini M, Varshosaz J, Nokhodchi A. Mater Sci Eng C Mater Biol Appl; 2019 May 30; 98():185-196. PubMed ID: 30813018 [Abstract] [Full Text] [Related]
8. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats. Nielsen LH, Gordon S, Holm R, Selen A, Rades T, Müllertz A. Eur J Pharm Biopharm; 2013 Nov 30; 85(3 Pt B):942-51. PubMed ID: 24075980 [Abstract] [Full Text] [Related]
9. A comparative assessment of solubility advantage from glassy and crystalline forms of a water-insoluble drug. Chawla G, Bansal AK. Eur J Pharm Sci; 2007 Sep 30; 32(1):45-57. PubMed ID: 17618092 [Abstract] [Full Text] [Related]
13. Preparation of a chemically stable quercetin formulation using nanosuspension technology. Gao L, Liu G, Wang X, Liu F, Xu Y, Ma J. Int J Pharm; 2011 Feb 14; 404(1-2):231-7. PubMed ID: 21093559 [Abstract] [Full Text] [Related]